Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Reify Health is raising $220,000,053.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ralph Passarella played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Reify Health
Reify Health provides cloud-based software that helps accelerate the development of new, life-saving therapies. StudyTeam, by Reify Health, is cloud-based software that helps clinical trial teams achieve faster, more predictable enrollment while eliminating the tedious work that saps productivity and study budget. StudyTeam gives sponsors, CROs, and clinical research sites earlier visibility to the full enrollment picture, and the insight they need to focus people and capital on work that yields the greatest return. The result is faster enrollment, stronger relationships between sponsors and investigator sites, and higher return on R&D investment.

To learn more about Reify Health, visit http://www.reifyhealth.com/

Contact:
Ralph Passarella, Chief Executive Officer
931-242-6378
ralph.passarella@reifyhealth.com
https://www.linkedin.com/in/ralphpassarella/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved